
Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.7%, driven by a pullback from Shin Nippon Biomedical Laboratories of 3.2%. Meanwhile, CellSource actually outperformed within the industry, gaining 6.1% in the last week. The industry has fallen 8.0% in the last year. Looking forward, earnings are forecast to grow by 14% annually.
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 21 Mar 2026 | JP¥142.9b | JP¥63.3b | -JP¥865,584,000.00 | 21.7x | -165.1x | 2.3x |
| Mon, 16 Feb 2026 | JP¥154.1b | JP¥62.8b | -JP¥1,250,880,000.00 | 24.4x | -123.2x | 2.5x |
| Wed, 14 Jan 2026 | JP¥151.7b | JP¥66.9b | JP¥72.2m | 21.8x | 2101x | 2.3x |
| Fri, 12 Dec 2025 | JP¥161.1b | JP¥67.6b | JP¥702.4m | 18.2x | 229.4x | 2.4x |
| Sun, 09 Nov 2025 | JP¥134.5b | JP¥67.8b | JP¥1.0b | 15.6x | 128.1x | 2x |
| Tue, 07 Oct 2025 | JP¥146.6b | JP¥66.5b | JP¥1.5b | 16.5x | 100.5x | 2.2x |
| Thu, 04 Sep 2025 | JP¥148.6b | JP¥66.5b | JP¥1.5b | 16.8x | 101.9x | 2.2x |
| Sat, 02 Aug 2025 | JP¥142.0b | JP¥66.0b | JP¥1.1b | 16.7x | 125.7x | 2.2x |
| Mon, 30 Jun 2025 | JP¥140.7b | JP¥66.0b | JP¥1.1b | 16.3x | 124.5x | 2.1x |
| Wed, 28 May 2025 | JP¥135.5b | JP¥66.0b | JP¥1.1b | 17x | 119.6x | 2.1x |
| Fri, 25 Apr 2025 | JP¥131.3b | JP¥64.2b | JP¥1.5b | 14.1x | 85.4x | 2x |
| Sun, 23 Mar 2025 | JP¥160.5b | JP¥64.8b | JP¥927.4m | 15.6x | 173.1x | 2.5x |
| Tue, 18 Feb 2025 | JP¥169.9b | JP¥64.7b | JP¥1.2b | 15.3x | 146.8x | 2.6x |
| Thu, 16 Jan 2025 | JP¥162.9b | JP¥62.0b | JP¥440.7m | 17.5x | 369.7x | 2.6x |
| Sat, 14 Dec 2024 | JP¥163.0b | JP¥62.0b | JP¥440.7m | 16.9x | 369.9x | 2.6x |
| Mon, 11 Nov 2024 | JP¥157.9b | JP¥62.6b | JP¥1.4b | 20.9x | 115x | 2.5x |
| Wed, 09 Oct 2024 | JP¥153.7b | JP¥61.5b | JP¥1.8b | 18x | 83.5x | 2.5x |
| Fri, 06 Sep 2024 | JP¥159.1b | JP¥61.5b | JP¥2.1b | 19x | 75.4x | 2.6x |
| Sun, 04 Aug 2024 | JP¥149.3b | JP¥61.8b | JP¥3.2b | 21.9x | 46.1x | 2.4x |
| Tue, 02 Jul 2024 | JP¥166.7b | JP¥61.8b | JP¥3.2b | 26.6x | 51.5x | 2.7x |
| Thu, 30 May 2024 | JP¥159.4b | JP¥61.8b | JP¥3.3b | 24.4x | 48.7x | 2.6x |
| Sat, 27 Apr 2024 | JP¥180.4b | JP¥62.3b | JP¥3.3b | 14.1x | 54.8x | 2.9x |
| Mon, 25 Mar 2024 | JP¥232.5b | JP¥155.4b | JP¥8.6b | 14x | 27x | 1.5x |
| Wed, 21 Feb 2024 | JP¥235.4b | JP¥155.3b | JP¥8.7b | 15.1x | 27.1x | 1.5x |
| Fri, 19 Jan 2024 | JP¥224.4b | JP¥167.1b | JP¥8.5b | 15.3x | 26.4x | 1.3x |
| Sun, 17 Dec 2023 | JP¥229.5b | JP¥167.1b | JP¥8.5b | 14.8x | 27x | 1.4x |
| Tue, 14 Nov 2023 | JP¥236.0b | JP¥168.1b | JP¥9.1b | 14.8x | 25.9x | 1.4x |
| Thu, 12 Oct 2023 | JP¥235.3b | JP¥179.3b | JP¥12.8b | 15x | 18.4x | 1.3x |
| Sat, 09 Sep 2023 | JP¥264.9b | JP¥179.3b | JP¥12.8b | 16.6x | 20.7x | 1.5x |
| Mon, 07 Aug 2023 | JP¥274.7b | JP¥179.8b | JP¥13.7b | 17.5x | 20x | 1.5x |
| Wed, 05 Jul 2023 | JP¥282.5b | JP¥178.5b | JP¥16.2b | 17.5x | 17.4x | 1.6x |
| Fri, 02 Jun 2023 | JP¥288.6b | JP¥178.3b | JP¥16.2b | 17.5x | 17.8x | 1.6x |
| Sun, 30 Apr 2023 | JP¥286.2b | JP¥174.9b | JP¥16.5b | 16.5x | 17.4x | 1.6x |
| Tue, 28 Mar 2023 | JP¥310.5b | JP¥171.9b | JP¥13.3b | 16.5x | 23.4x | 1.8x |
23.4x
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | -0.63% | |
| Healthcare | -1.54% | |
| Life Sciences | -1.71% | |
| Clinical Research and Equipment | -1.71% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4880 CellSource | JP¥401.00 | 6.1% +JP¥456.5m | -50.0% | PE90x | |
| 7707 Precision System Science | JP¥225.00 | 4.7% +JP¥274.6m | -2.6% | PS1.2x | |
| 4572 Carna Biosciences | JP¥351.00 | 3.2% +JP¥211.0m | 23.6% | PS11.6x | |
| 130A Veritas In Silico | JP¥475.00 | 1.7% +JP¥51.9m | -42.5% | PS33.8x | |
| 6190 PhoenixBio | JP¥455.00 | 1.8% +JP¥32.6m | 18.2% | PS1.2x |